Immune System Related Kidney Disease
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00001979|
Recruitment Status : Recruiting
First Posted : January 21, 2000
Last Update Posted : October 8, 2020
Kidney diseases related to the immune system include, nephrotic syndrome, glomerulonephritis, membranous nephropathy, lupus nephritis, and nephritis associated with connective tissue disorders.
This study will allow researchers to admit and follow patients suffering from autoimmune diseases of the kidney. It will attempt to provide information about the causes and specific abnormalities associated with autoimmune kidney disease.
Patients with kidney disease as a result of their immune system, and patients with diseases of the immune system who may later develop kidney disease, will be potential subjects for this study.
Patients will undergo a history and physical examination, and standard laboratory test to more closely understand the causes, signs, symptoms, and responses to medication of these diseases. Based on these evaluations the patients may qualify as candidates for other experimental studies. At any time these patients may be asked to submit blood or urine samples for further research.
|Condition or disease|
|Kidney Disease Nephrotic Syndrome|
|Study Type :||Observational|
|Estimated Enrollment :||999999 participants|
|Official Title:||Studies of Immunologically-Mediated Kidney Diseases|
|Actual Study Start Date :||June 25, 1992|
Patients with known or suspected immunologically-mediated kidney diseases or immunologically-mediated diseases with potential for kidney disease.
- Provision of biospecimens [ Time Frame: On-going ]Patients with autoimmune diseases for whom there are no current experimental treatment protocols can be admitted for study and follow- up; they will provide a ready pool of candidates who can be asked to provide blood specimens for ongoing laboratory studies.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00001979
|Contact: Meryl A Waldman, M.D.||(301) firstname.lastname@example.org|
|United States, Maryland|
|National Institutes of Health Clinical Center, 9000 Rockville Pike||Recruiting|
|Bethesda, Maryland, United States, 20892|
|Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR) 800-411-1222 ext TTY8664111010 email@example.com|
|Principal Investigator:||Meryl A Waldman, M.D.||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|